Macrophage migration inhibitory factor is involved in endovascular trophoblast cell function in vitro by Vilotic, Aleksandra et al.
EXCLI Journal 2019;18:1007-1018 – ISSN 1611-2156 





MACROPHAGE MIGRATION INHIBITORY FACTOR IS INVOLVED 
IN ENDOVASCULAR TROPHOBLAST CELL FUNCTION IN VITRO 
 
Aleksandra Vilotić1, Milica Jovanović Krivokuća*1, Ivana Stefanoska1,  
Svetlana Vrzić Petronijević2, Miloš Petronijević2, Ljiljana Vićovac1 
 
1 Laboratory for Biology of Reproduction, Institute for the Application of Nuclear Energy, 
INEP, University of Belgrade, Banatska 31b, 11080 Belgrade, Serbia 
2 Clinic of Obstetrics and Gynecology, Clinical Center of Serbia, Koste Todorovića 26, 
11000 Belgrade, Serbia 
 
* Corresponding author: Milica Jovanović Krivokuća, Institute for the Application of  
Nuclear Energy, INEP, University of Belgrade, Banatska 31b, 11080 Belgrade, Serbia; 









Macrophage migration inhibitory factor (MIF) is a multifunctional cytokine abundantly present at the feto-mater-
nal interface proposed to play a role in establishment of pregnancy. We have previously shown that pharmacolog-
ical inhibition of enzymatic activity of MIF decreases extravillous trophoblast invasion and migration in vitro. 
This study aimed to further elucidate potential role of endogenous trophoblast MIF, and to assess its importance 
for endovascular trophoblast cell function in particular. Attenuation of MIF by siRNA reduced HTR-8/SVneo cell 
invasion through Matrigel (59 % of control), expression of integrin α1 (86 % of control) and levels of MMP2 and 
MMP9 (87 % and 57 % of control, respectively). MIF specific siRNA reduced the ability of HTR-8/SVneo to 
differentiate in to endothelial-like phenotype, as determined by Matrigel tube formation assay. The total tube 
length was decreased to 68.6 %, while the number of branching points was reduced to 57.8 % of control. HTR-
8/SVneo cell capacity to integrate into HUVEC monolayers was reduced by knock-down of MIF. This could be 
partly caused by reduced N-cadherin expression to 63 % of control, which decreased with knock-down of MIF, as 
the expression of this protein was recently shown essential for trophoblast-endothelial interaction. These novel 
findings indicate a novel role for trophoblast MIF in spiral artery remodeling process.  
 





Embryo implantation in mammals with 
hemochorial placenta involves multiple criti-
cal steps, such as embryo attachment to the 
uterine epithelium, translocation in to the 
uterine stroma and subsequent invasion of lo-
cal tissues by extravillous trophoblast (EVT) 
lineage formed along the process. During the 
first trimester of human pregnancy interstitial 
EVT invade decidual stroma and part of my-
ometrium anchoring placenta to the mother’s 
uterus while endovascular EVT invade decid-
ual spiral arteries transforming their vessel 
walls by degrading and replacing endothelial 
and smooth muscle cell layers (Pijnenborg, 
1998). Remodeled spiral arteries become di-
lated high-flow conduits escaping vasomotor 
control thus enabling constant supply of ma-
ternal blood to the feto-maternal interface 
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which is important for normal development of 
the growing fetus (Pijnenborg, 1998). 
During endovascular invasion EVT ac-
quires endothelial-like phenotype which fa-
cilitates trophoblast integration and subse-
quent replacement of the endothelial cells of 
the spiral arteries. Adhesive molecule reper-
toire of endovascular EVT changes allowing 
direct cell-cell interaction between tropho-
blast and endothelial cells (Burrows et al, 
1994; Multhaup et al., 2018; Zhou, et al., 
1997a). Spiral arteries remodeling includes 
endothelial cell apoptosis and extracellular 
matrix catabolism (Ashton et al., 2005; Harris 
et al., 2010). 
Reduced spiral artery remodeling is asso-
ciated with serious pregnancy pathologies 
such as pre-eclampsia and fetal growth re-
striction (Kaufmann et al., 2003; Pijnenborg 
et al., 2011; Zhou et al., 1997b). Although 
several mechanisms were proposed endovas-
cular invasion and spiral artery remodeling 
are still not fully understood. Further research 
on molecules involved and underlying mech-
anisms of these processes is expected to lead 
to improved understanding of both physiolog-
ical and pathological events, which could aid 
in early detection of the aberrant blood vessel 
transformation. 
MIF is a multifunctional cytokine highly 
expressed at the feto-maternal interface dur-
ing pregnancy (Arcuri et al., 1999, 2001). The 
highest level of MIF in human placenta is de-
termined in early pregnancy (Ietta et al., 
2007) predominantly expressed in villous cy-
totrophoblast and extravillous trophoblast 
(Arcuri et al., 1999). At the end of the first tri-
mester MIF in placenta is decreasing and is 
maintained to the term (Ietta et al., 2007). Alt-
hough available data on MIF in human preg-
nancy imply important role of this cytokine 
for EVT function and placentation, specific 
contribution of MIF still remains to be eluci-
dated. Our group previously showed that MIF 
supports EVT invasion and migration in vitro, 
while pharmacological inhibition of MIF 
abolished these processes (Jovanović 
Krivokuća et al., 2015). MIF protects tropho-
blast cells from excessive apoptosis (Ietta et 
al., 2018) and is involved in immune privilege 
at the feto-maternal interface (Arcuri et al., 
2006) and placental response to infection (De 
Oliveira Gomes et al., 2011; Jovanović-
Krivokuća et al., 2016).  
This study aimed to further elucidate rele-
vance of endogenous trophoblast MIF for 
early pregnancy events, more specifically 
endovascular differentiation of EVT and its 
potential contribution to trophoblast-endothe-
lial interaction, important for spiral artery re-
modeling. 
 
MATERIAL AND METHODS 
Cell culture 
The HTR-8/SVneo (donated by Dr 
Charles H Graham) (Graham et al., 1993) 
were maintained in RPMI 1640 medium 
(Gibco, UK) supplemented with 10 % heat in-
activated fetal calf serum (v/v) (FCS, Sigma-
Aldrich, USA) and 1 % antibiotic/antimy-
cotic solution (Capricorn Scientific, Ger-
many) (HTR medium). HUVEC were isolated 
from umbilical cords (5 individual cases) col-
lected after term deliveries (approved by the 
Ethical committee of the Clinical Centre of 
Serbia, approval no. 57/10) by sequential 
short trypsinization as previously described 
(Jiménez et al, 2013). Collected cells were 
seeded on 0.2 % gelatin-coated plates and 
maintained in M199 medium (Lonza, Bel-
gium) supplemented with 20 % heat inacti-
vated FCS, 2 mM L-Glutamine (Torlak, Ser-
bia), 0.4 % endothelial cell growth supple-
ment containing heparin (ECGS/H) (Pro-
moCell GmbH, Germany) and 1 % antibi-
otic/antimycotic solution (HUVEC medium). 
 
MIF siRNA transfection 
Predesigned specific siRNA for MIF (Si-
lencer Select Validated siRNA, s8780) and 
negative control (Silencer Negative Control 
siRNA #2, AM4613) were purchased from 
Ambion (Thermo Fisher Scientific Inc., 
USA). HTR-8/SVneo cells were transfected 
with 30 nM siRNA using Lipofectamine 
RNAiMAX (Invitrogen, USA) according to 
manufacturer’s instruction in antibiotic-free 
Opti-MEM I GLUTAMAX I Reduced Serum 
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Medium (Opti-MEM) (Gibco, UK). There 
were 3 experimental groups: L – cells treated 
with Lipofectamine only, S – cells transfected 
with negative control siRNA, and siMIF - 
cells transfected with MIF siRNA. After 48 h 
or 72 h transfected cells were collected for 
further analyses. 
 
Cell viability assay 
HTR-8/SVneo cell viability was assessed 
by MTT test 48 h and 72 h following transfec-
tion. Cells were collected and seeded in 96-
well plates at 5 x 104 cells/well in 100 µl of 
Opti-MEM medium. 10 µl of MTT (5 mg/ml 
in PBS) was added to each well and the cells 
were incubated 3 h at 37 °C, 5 % CO2. At the 
end of the incubation, 100 µl of 10 % SDS 
(0.01 N HCl) was added to each well and the 
plate was further incubated at 37 °C overnight 
to ensure complete solubilization of forma-
zan. The absorbance was read at 540 nm using 
a microplate reader (LKB, Austria). 
 
Cell invasion assay 
HTR-8/SVneo cells were collected 48 h 
after transfection and transwell invasion assay 
was conducted as previously described with 
minor changes (Stefanoska et al., 2013). 
Briefly, 1 x 105 cells were seeded on top of 
Matrigel (Corning, USA)-coated cell culture 
inserts (8 µm pore size, Merck KGaA, Ger-
many). After 24 h incubation, cells on the up-
per side of filter inserts were gently removed 
with cotton swab. After rinsing and fixation, 
cells were stained by Giemsa, and the occu-
pied pores of the entire filter were counted. 
All experiments were done in Opti-MEM me-
dium. 
 
Quantitative real-time PCR  
qPCR analyses were done as previously 
described (Bojić-Trbojević et al., 2019). Ex-
pression levels of MIF gene (MIF_F: CCG-
GACAGGGTCTACATCA; MIF_R: 
ATTTCTCCCCACCAGAAGGT) were nor-
malized to the housekeeping gene GAPDH 
(GAPDH_F: GAAGGTGAAGGTCGGAGT; 
GAPDH_R: GAAGATGGTGATGGGAT-
TTC). Calculations were made by the com-
parative ΔΔCt method (Livak and Schmittgen, 
2001). 
 
SDS-PAGE and immunoblot 
HTR-8/SVneo whole cell lysates prepared 
48 h or 72 h after transfection, or cell condi-
tioned media, were analyzed by Western blot 
after protein separation on 12.5 % gel as pre-
viously described (Bojić-Trbojević et al., 
2019) using anti-MIF antibody (0.5 mg/ml, 
R&D Systems, UK). The obtained signals 
were scanned and analyzed by the Image-
Master TotalLab v2.01 program (Amersham 
Biosciences, Inc., USA). MIF protein expres-
sion levels were normalized to the expression 
of GAPDH (anti-GAPDH, 1:12000, Cell Sig-
naling Technology Inc, USA).  
 
Flow cytometry 
HTR-8/SVneo cells were collected 48 h or 
72 h after transfection by 0.25 % tryp-
sin/0.02 % EDTA. Cells were permeabilized 
and prepared further for flow cytometry and 
analyzed as previously described (Bojić-
Trbojević et al., 2019) using following pri-
mary antibodies: anti-MIF (0.5 µg/ml, R&D 
Systems, UK), anti-integrin α1 (1 µg/ml, 
R&D Systems, UK), anti-integrin α5 (1:25; 
BIIG2), anti-integrin β1 (1:50; AIIB2) (kind 
gift from Susan Fisher Lab, University of Cal-
ifornia, San Francisco, USA), and anti-N-cad-
herin (10 µg/ml, Thermo Fisher Scientific, 
USA), and anti-mouse Alexa Flour 488 sec-
ondary antibody (Molecular Probes, Life 




Matrix metalloproteinase (MMP) gelati-
nolytic activity was determined in condi-
tioned media of HTR-8/SVneo cells collected 
48 h after transfection by SDS-PAGE gelatin 
zymography as described previously (Bojić-
Trbojević et al., 2019). Zymograms were 
scanned and analyzed by the ImageMaster 
TotalLab v2.01 program (Amersham Biosci-
ences Inc., USA).  
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HTR-8/SVneo tube formation 
Tube formation assay was done as previ-
ously described with minor changes 
(Beltrame et al, 2018). Briefly, 96-well plates 
were coated with 40 μl/well of growth factor-
reduced Matrigel diluted with Opti-MEM to 
final concentration of 7.5 mg/ml and incu-
bated 30 min at 37 °C to solidify. HTR-
8/SVneo cells (4 x 104 cells/well) were seeded 
on coated wells in Opti-MEM 72 h after trans-
fection. Images of tube structures were taken 
after 6 h of incubation using inverted light mi-
croscope (x10 magnification, Nikon TMS, 
Nikon Instruments, Inc., USA) and digital 
camera (Canon, PowerShot S50, Canon Inc., 
Japan). Four non-overlapping fields of view 
per well were analyzed. Total tube length and 
number of branching points were quantified 
using Image J software (National Institutes of 
Health, USA). The branching points were 
considered as a point from which two or more 
tubes branched. 
 
HUVEC viability test and determination of 
adherent cell number 
The viability and adherent cell number of 
HUVEC were assessed using the MTT test or 
crystal violet staining as previously described 
with minor changes (Stefanoska et al., 2013). 
HUVEC were seeded in gelatin-coated 96-
well plates (2 x 104 cells/well) in 100 μl of 
HUVEC medium and maintained overnight in 
a humidified chamber. Cells were rinsed and 
incubated for 24 h in a mixture of conditioned 
media of transfected HTR-8/SVneo cells col-
lected 72 h after transfection and HUVEC 
medium, ratio 2:1, 100 μl/well. For MTT test, 
10μl of MTT (5 mg/ml) was added to each 
well upon treatment. After incubation for 2 h 
at 37 ̊ C, medium was replaced by 1-propanol. 
Absorbance was measured at 540 nm using a 
microplate reader (LKB, Austria). 
For crystal violet staining, the cells were 
dried, fixed and stained with 0.05 % crystal 
violet in 25 % methanol. The incorporated 
dye was dissolved in 0.1 M sodium citrate in 
50 % ethanol. Optical density was read at 540 
nm. The results of three experiments with six 
replicates are presented as a percentage of 
lipofectamine control values. 
 
Trophoblast integration into endothelial 
cell monolayers 
Trophoblast-endothelial cell monolayer 
co-culture was used to investigate ability of 
HTR-8/SVneo cells to integrate into endothe-
lium and replace the endothelial cells, as pre-
viously described with minor modifications 
(Bainbridge et al., 2009). Briefly, HUVEC 
cells were seeded onto gelatin coated 13 mm 
glass coverslips and grown in HUVEC me-
dium to full confluence. HTR-8/SVneo cells 
were collected 72 h after transfection, labelled 
with 15 μM Cell Tracker Blue CMAC dye 
(Molecular Probes, Invitrogen, Thermo 
Fisher Scientific Inc., USA) according to the 
manufacturer's instruction and seeded onto 
HUVEC’s monolayer at 7.5 x 104 cells/well/ 
24-well plates in 1:1 mixture of HUVEC and 
HTR medium. After 24 h co-cultures were ex-
amined by Carl Zeiss Axio Imager.A1 micro-
scope with AxioCam MRm camera (Carl 
Zeiss, Germany). Captures were taken with 
10x objective all over the coverslips and 
HTR-8/SVneo cell integration into endothe-
lial cell monolayers was quantified as a per-
centage of total field area occupied by troph-
oblast cell islands (blue labeled) using Image 




The data was analyzed using GraphPad 
Prism Demo Software (GraphPad Software, 
Inc., USA). One-way analysis of variance 
(ANOVA) with Tukey post-hoc test (α = 
0.05) was used for statistical analyses since 
data passed normality test. Values were con-
sidered significantly different when p < 0.05. 
All experiments were done at least three times 
in duplicate and the mean values for the 
lipofectamine control was set to the 100 % 
and the data were presented as percentage of 
the lipofectamine control unless otherwise 
stated. 
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MIF specific siRNA decreases MIF  
expression, secretion and Matrigel  
invasion by HTR-8/SVneo cells  
Efficiency of MIF silencing was verified 
at mRNA (Figure 1a) and protein levels in 
whole cell lysates (Figure 1b,c) and in condi-
tioned media (Figure 1c, d). MIF mRNA ex-
pression was reduced to 15 % of control after 
48 h and to 3 % of control after 72 h of culture 
(Figure 1a, p<0.001). In whole cell lysates 
MIF protein was reduced to 45 % and 38 %, 
at 48 h and 72 h after transfection, respec-
tively (Figure 1b; p<0.001). Secreted MIF, 
detected in cell conditioned media was re-
duced to 63 % (p<0.01) and 37 % (p<0.001) 
of lipofectamine control, after 48 h and 72 h 
respectively (Figure 1d). Silencing of MIF 
had no effect on HTR-8/SVneo cell viability 
neither 48 h nor 72 h following transfection 
(Figure 1e). The importance of endogenous 
MIF for trophoblast cell function was studied 
using in vitro Matrigel invasion assay. HTR-
8/SVneo cells, 48 h following transfection, 
had reduced capacity for Matrigel invasion 
down to 59 % of control (Figure 1f; p<0.01). 
 
Figure 1: MIF specific siRNA reduces MIF expression and cell invasion of HTR-8/SVneo cells. MIF 
specific siRNA effectively reduced mRNA (a) and protein expression (b, c, d) in whole cell lysates (b, 
c) and secreted MIF in conditioned media (c, d). Representative Western blots are shown in c. Inhibition 
of MIF expression had no effect on cell viability (e), but led to a significant decrease in HTR-8/SVneo 
cell invasion in Matrigel invasion assay (f). Data are presented as mean +SEM, ** p<0.01, *** p<0.001. 
n = 5 (a), n = 3 (b, f), n=4 (d, e)
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The effect of MIF silencing on the  
expression of integrins and MMPs in  
HTR-8/SVneo cells 
Possible mediators of reduction in inva-
sive capacity of HTR-8/SVneo cells were 
sought among integrin subunits and MMPs. 
Integrin α1 was reduced to 86 % of control 
(Figure 2a; p<0.01), as shown by flow cytom-
etry. Gelatin zymography revealed that both 
tested MMPs – MMP2 and MMP9 were de-
creased to 87 % (p<0.05) and 57 % (p<0.001) 
of control, respectively (Figure 2b, c, d). 
 
 
Figure 2: The effect of MIF knockdown by specific siRNA on mediators of trophoblast invasion in HTR-
8/SVneo cells. Integrin subunit α1 was significantly reduced, while subunits α5 and β1 were not changed 
as assessed by flow cytomerty (a). Gelatine zymography showed a significant decrease in both MMP2 
(b) and MMP9 (c) levels. Representative zymogram is shown in d. MFI – mean fluorescent intensity. 
Data are presented as mean +SEM, * p<0.05, ** p<0.01, *** p<0.001, n =3-6 
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MIF silencing impairs endovascular  
differentiation of HTR-8/SVneo cells and 
integration into endothelial cell monolayer 
The importance of MIF for differentiation 
of HTR-8/SVneo cells to endovascular troph-
oblast-like phenotype was studied using tube 
formation assay on Matrigel (Figure 3a). 
HTR-8/SVneo cells display tube formation 
ability in culture (Highet et al., 2012). Knock-
down of MIF decreased cell ability to form 
tubes. The total tube length was decreased to 
68.6 % (32397±1137 and 22218±1352 pixels 
for L and siMIF respectively, p<0.001) (Fig-
ure 3b), while the number of branching points 
was reduced to 57.8 % of lipofectamine con-
trol (99.6±3.8 and 57.6±3 branching points 




Figure 3: The effect of inhibition of MIF expression on HTR-8/SVneo cell acquisition of endothelial-like 
phenotype in tube formation assay on Matrigel (a). Total tube length (b) and total number of branching 
points (c) were significantly reduced. Data are presented as mean +SEM, *** p<0.001. n = 4
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Interaction of trophoblast and endothe-
lium was studied using direct co-culture of 
HTR-8/SVneo cells and HUVEC. MIF 
knockdown decreased the capacity of HTR-
8/SVneo cells to replace HUVEC cells to 
73 % of control (p<0.001, Figure 4a, b). The 
possibility that secreted HTR-8/SVneo cell 
factors modulate HUVEC survival was stud-
ied using conditioned media of transfected 
HTR-8/SVneo cells in MTT and adherent cell 
number assays of HUVEC. These media had 
no effect on HUVEC survival (Figure 4c, d).  
The expression of N-cadherin, as possible 
mediator of reduction in HTR-8/SVneo cell 
integration into HUVEC monolayer, was 
studied by flow cytometry. The expression of 
this adhesion molecule was reduced to 63 % 
of control (p<0.05, Figure 4e) after knock-
down of MIF. 
 
 
Figure 4: MIF specific siRNA decreases endothelium replacement capacity of HTR-8/SVneo cells. In-
hibition of MIF expression by siRNA (72 h) led to a significant reduction in the capacity of HTR-8/SVneo 
cells to replace endothelium in trophoblast-HUVEC co-culture model (a, b). Conditioned media from 
MIF-silenced HTR-8/SVneo cells had no significant effect on HUVEC cell viability in MTT test (c), or 
adherent cell numbers (crystal violet staining) compared to control. N-cadherin expression was signifi-
cantly reduced in HTR-8/SVneo cells following MIF knockdown as assessed by flow cytometry (e). MFI 
– mean fluorescent intensity. Data are presented as mean +SEM, * p<0.05, *** p<0.001. n = 4 (b), n = 
3 (c, d)
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Implantation of the human embryo and 
placentation takes place in a proinflammatory 
environment. Many of the cytokines/chemo-
kines contribute to these processes by stimu-
lating or limiting trophoblast invasion (Lash, 
2015; Pollheimer et al., 2018). MIF is abun-
dantly present at the feto-maternal interface, 
produced by trophoblast itself, as well as var-
ious maternal cell types such as decidual stro-
mal cells and immune cells (Arcuri et al., 
2001). Our previous results showed that 
blocking of MIF by ISO-1 decreased tropho-
blast cell migration and invasion, while addi-
tion on rhMIF had the opposite effect 
(Jovanović Krivokuća et al., 2015). ISO-1 is 
a small chemical inhibitor designed to block 
tautomerase activity of MIF, previously 
shown essential for its proinflammatory ac-
tion (Al-Abed et al., 2005). Here, the role of 
endogenous trophoblast MIF was further in-
vestigated, and its relevance for endovascular 
trophoblast cell function in particular. The 
data presented here show that attenuation of 
endogenous MIF decreased HTR-8/SVneo 
cell invasion, which is in keeping with the 
previously reported reduction observed when 
extracellular MIF tautomerase activity was 
neutralizated with ISO-1. Taken together, 
MIF is shown to act both as an autocrine stim-
ulator of trophoblast invasion, but also in a 
paracrine manner, since our previous results 
showed that addition of ISO-1 to decidual 
stromal cell conditioned media decreased 
their pro-invasive action on trophoblast 
(Jovanović Krivokuća et al., 2015). Other cell 
types have also shown reduced migratory 
and/or invasive capacity when MIF activity 
was abolished after knockdown of MIF by 
specific siRNA, such as endometrial cancer 
cell line HEC-1A (Md Fuzi et al., 2018), oral 
squamous cell carcinoma (Zeng et al., 2016), 
mouse colorectal cancer cell line CT-26 (Wu 
et al., 2017). Both siRNA-mediated silencing 
of MIF, and the use of specific inhibitors led 
to a significant decrease in the invasive ability 
of the gall bladder cancer cell lines 
(Subbannayya et al., 2015). Inhibition of lung 
adenocarcinoma cell line invasion by ISO-1 
as well as MIF siRNAs was also reported 
(Rendon et al., 2007).  
It has been well documented that as EVT 
acquires invasiveness, changes in integrin 
repertoire (loss of α6β4, and upregulation of 
α1β1and α5β1) occur (Damsky et al., 1992). 
Moreover, invasive EVT produces extracellu-
lar matrix-degrading enzymes, such as MMPs 
(Lala and Graham, 1990; Librach et al., 
1991). Previously, we have shown that block-
ing MIF by ISO-1 decreased integrin α1 
(Jovanović Krivokuća et al., 2015), which 
was replicated here with MIF siRNA ap-
proach. Attenuation of endogenous MIF had 
negative effect on gelatinolytic activity of 
MMP2 and MMP9. This reduction could con-
tribute to reduced Matrigel invasion of MIF 
silenced HTR-8/SVneo cells, since this pro-
cess requires action of proteolytic enzymes. 
Similarly, blocking MIF by ISO-1 in our pre-
vious study also involved reduction in MMP2 
and MMP9 (Jovanović Krivokuća et al., 
2015). Not much is currently known regard-
ing the influence of MIF inhibition by siRNA 
on integrin and MMP expression. Integrin β1 
was supressed in mouse colon 26 cells (Sun et 
al., 2005), while MMP9 was reduced by MIF 
siRNA in oral squamous carcinoma cells 
(Zeng et al., 2016). 
The main focus of our study was to estab-
lish whether trophoblast MIF might be in-
volved in spiral artery remodeling process. 
The data presented here show that MIF may 
be an important factor in trophoblast differen-
tiation to endovascular phenotype, since 
HTR-8/SVneo cells were significantly less 
capable of tube formation on Matrigel after 
knockdown of this cytokine. The mechanism 
of endothelium replacement by trophoblast is 
still not completely elucidated, but it is known 
to involve both endothelium apoptosis and re-
gression (Ashton et al., 2005; Pijnenborg et 
al., 2006). Both invading trophoblast and vas-
cular cells produce proteolytic enyzmes, ena-
bling degradation of subendothelial basement 
membrane. Trophoblast and vascular smooth 
muscle cells were suggested to act coopera-
tively to degrade elastin in basal membrane of 
the vessel, by producing elastase MMP-12 
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(Harris et al., 2010). In our study, HUVEC 
cells were used as model for endothelium. 
Previous study has reported that there was no 
difference between HUVEC and decidual en-
dothelial cells with respect to response to 
trophoblast (Ashton et al., 2005). Using co-
culture of HTR-8/SVneo cells with HUVEC, 
we have shown that trophoblast MIF might be 
involved in remodeling process, since MIF si-
lencing significantly decreased trophoblast 
capacity to integrate into HUVEC monolay-
ers. Secreted factors dependent on trophoblast 
MIF, do not change HUVEC viability, as con-
ditioned media of MIF knockdown HTR-
8/SVneo cells had no effect. Changes in the 
expression of various adhesion molecules oc-
cur during interstitial and endovascular inva-
sion (Damsky et al., 1992; Damsky and 
Fisher, 1998; Zhou et al., 1997a). Endovascu-
lar trophoblast was shown to express endothe-
lial adhesion molecules such as VE-(endothe-
lial) cadherin, platelet-endothelial adhesion 
molecule-1, vascular endothelial adhesion 
molecule-1, and a4-integrins, and integrin 
αVβ3 (Zhou al., 1997a). Recently, N-cadherin 
was reported essential for the interaction of 
trophoblast and endothelium (Multhaup et al., 
2018). This cadherin was specifically ex-
pressed in HTR-8/SVneo cell line, which 
showed much more pronounced interaction 
with pre-formed HUVEC networks compared 
to other used trophoblast cell lines, Jeg-3, 
AC-1M32 and AC-H3P (Multhaup et al., 
2018). Knockdown of N-cadherin by specific 
siRNA in HTR-8/SVneo cells led to 
disruption of interaction with endothelium 
networks (Multhaup et al., 2018). We there-
fore wondered whether this protein might be 
mediating the reduction in HTR8/SVneo inte-
gration into HUVEC monolayer observed 
here. Indeed, this hypothesis was confirmed, 
since MIF specific siRNA treatment resulted 
in decreased expression of N-cadherin. How-
ever, potential action of other mediators is not 
excluded, and merrits further attention. 
Taken together, our results confirm that 
MIF participates in multiple early pregnancy 
events necessary for normal implantation and 
placentation, and show that trophoblast MIF 
significantly contributes to various aspects of 
trophoblast function.  
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